Fund Holdings — Richmond Brothers, Inc.

Total Portfolio Value:
$50.56M
Total Bought:
$1.31M
Total Sold:
$6.19M
Net Transaction:
-$4.88M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Invesco Qqq TrUNIT SER 141,97238,703-3,269$18.64M$18.54M36.67%-$92.7K
MiMedx Group, Inc.(MDXG)1,097,016917,343-179,673$8.45M$6.36M12.57%-$2.09M
Apple Inc.(AAPL)30,13927,758-2,381$5.17M$5.85M11.56%+$678.3K
Berkshire Hathaway Inc DelCL B13,69312,742-951$5.76M$5.18M10.25%-$574.7K
Guggenheim Strategic Opportunities FundCOM SBI(GOF)302,107296,824-5,283$4.33M$4.43M8.75%+$99.4K
Microsoft Corporation(MSFT)5,1214,544-577$2.15M$2.03M4.02%-$123.3K
Durect Corp768,3441,072,014+303,670$929.7K$1.38M2.74%+$453.2K
Heron Therapeutics, Inc.(HRTX)296,706356,558+59,852$821.9K$1.25M2.47%+$426.1K
Ishares TrISHARES BIOTECH8,2497,290-959$1.13M$1.00M1.98%-$131.3K
Nuveen AMT-Free Municipal Credit Income Fund(NVG)45,85044,024-1,826$557.1K$548.6K1.08%-$8.5K
Proshares TrULTRAPRO QQQ
ULTRAPRO QQQ
5,6137,373+1,760$345.5K$544.3K1.08%+$198.7K
Amazon.com, Inc.(AMZN)2,7972,7970$504.5K$540.5K1.07%+$36.0K
Ishares TrCORE S P500 ETF908902-6$477.4K$493.6K0.98%+$16.2K
Rockwell Medical, Inc.(RMTI)322,251276,828-45,423$535.0K$487.2K0.96%-$47.7K
Alphabet Inc.CL C(GOOG)1,9841,9840$302.1K$363.9K0.72%+$61.8K
Axonics Inc4,7494,7490$327.5K$319.3K0.63%-$8.3K
Opus Genetics, Inc.(IRD)227,461191,304-36,157$457.2K$292.7K0.58%-$164.5K
Applied Therapeutics Inc61,82761,8270$420.4K$288.7K0.57%-$131.7K
McDonald's Corporation(MCD)9489480$267.2K$241.5K0.48%-$25.7K
Oncternal Therapeutics Inc24,69624,6960$222.3K$187.7K0.37%-$34.6K
Alvotech(ALVO)013,966+13,966$0$169.8K0.34%+$169.8K
SoFi Technologies, Inc.(SOFI)010,083+10,083$0$66.6K0.13%+$66.6K
Air Industries Group(AIRI)34,8050-34,805$163.6K$0—-$163.6K
Ark Etf TrINNOVATION ETF
INNOVATION ETF
31,6390-31,639$1.58M$0—-$1.58M
The Procter & Gamble Company(PG)1,2930-1,293$209.8K$0—-$209.8K
Verizon Communications Inc.(VZ)4,9470-4,947$207.6K$0—-$207.6K
Page 1 of 1
Richmond Brothers, Inc. — 13F Holdings — Q2 2024 | TickerTrail